These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28004386)

  • 1. Proinflammatory signaling functions of thrombin in cancer.
    Ebrahimi S; Rahmani F; Behnam-Rassouli R; Hoseinkhani F; Parizadeh MR; Keramati MR; Khazaie M; Avan A; Hassanian SM
    J Cell Physiol; 2017 Sep; 232(9):2323-2329. PubMed ID: 28004386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of thrombin in the pathogenesis of central nervous system inflammatory diseases.
    Ebrahimi S; Jaberi N; Avan A; Ryzhikov M; Keramati MR; Parizadeh MR; Hassanian SM
    J Cell Physiol; 2017 Mar; 232(3):482-485. PubMed ID: 27458694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin generation and the pathogenesis of cancer.
    Ruf W; Mueller BM
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():61-8. PubMed ID: 16673267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
    Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L
    Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of thrombin and protease-activated receptors in inflammation.
    Ma L; Dorling A
    Semin Immunopathol; 2012 Jan; 34(1):63-72. PubMed ID: 21809138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
    Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-activated receptors - biology and role in cancer.
    Hempel D; Sierko E; Wojtukiewicz MZ
    Postepy Hig Med Dosw (Online); 2016 Jul; 70(0):775-86. PubMed ID: 27383574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease signaling in tumor progression.
    Camerer E
    Thromb Res; 2007; 120 Suppl 2():S75-81. PubMed ID: 18023718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptors and their biological role - focused on skin inflammation.
    Guenther F; Melzig MF
    J Pharm Pharmacol; 2015 Dec; 67(12):1623-33. PubMed ID: 26709036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin and activated coagulation factor X stimulate the release of cytokines and fibronectin from nasal polyp fibroblasts
    Shimizu S; Tojima I; Takezawa K; Matsumoto K; Kouzaki H; Shimizu T
    Am J Rhinol Allergy; 2017 Jan; 31(1):13-18. PubMed ID: 28234145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptors in neuronal development, neurodegeneration, and neuroprotection: thrombin as signaling molecule in the brain.
    Rohatgi T; Sedehizade F; Reymann KG; Reiser G
    Neuroscientist; 2004 Dec; 10(6):501-12. PubMed ID: 15534036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor Xa Signaling Contributes to the Pathogenesis of Inflammatory Diseases.
    Ebrahimi S; Rezaei S; Seiri P; Ryzhikov M; Hashemy SI; Hassanian SM
    J Cell Physiol; 2017 Aug; 232(8):1966-1970. PubMed ID: 27925197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-activated receptors, cyclo-oxygenases and pro-angiogenic signalling in endothelial cells.
    Wheeler-Jones CP; Farrar C; Garonna E
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1179-83. PubMed ID: 19909242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated receptors in the musculoskeletal system.
    Mackie EJ; Loh LH; Sivagurunathan S; Uaesoontrachoon K; Yoo HJ; Wong D; Georgy SR; Pagel CN
    Int J Biochem Cell Biol; 2008; 40(6-7):1169-84. PubMed ID: 18243039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling pathways involved in proteinase-activated receptor1-induced proinflammatory and profibrotic mediator release following lung injury.
    Mercer PF; Deng X; Chambers RC
    Ann N Y Acad Sci; 2007 Jan; 1096():86-8. PubMed ID: 17405919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-unique coagulation system protein with multifaceted impacts on cancer and metastasis.
    Wojtukiewicz MZ; Hempel D; Sierko E; Tucker SC; Honn KV
    Cancer Metastasis Rev; 2016 Jun; 35(2):213-33. PubMed ID: 27189210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characteristics of thrombin in osteoarthritic pathogenesis and treatment.
    Chou PY; Su CM; Huang CY; Tang CH
    Biomed Res Int; 2014; 2014():407518. PubMed ID: 25313362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors.
    Yonamine CM; Kondo MY; Nering MB; Gouvêa IE; Okamoto D; Andrade D; da Silva JA; Prieto da Silva AR; Yamane T; Juliano MA; Juliano L; Lapa AJ; Hayashi MA; Lima-Landman MT
    Toxicon; 2014 Mar; 79():64-71. PubMed ID: 24412460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.
    Hansen KK; Oikonomopoulou K; Li Y; Hollenberg MD
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):377-92. PubMed ID: 17952408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype.
    Nierodzik ML; Karpatkin S
    Cancer Cell; 2006 Nov; 10(5):355-62. PubMed ID: 17097558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.